• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. EVALUATION OF TEAR FILM STATUS IN PATIENTS USING ANTI-GLAUCOMA MEDICATION

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

EVALUATION OF TEAR FILM STATUS IN PATIENTS USING ANTI-GLAUCOMA MEDICATION

    Author

    • Dr. Kilari Sindhu, Dr. Abhay Lune, Dr. Col OK Radhakrishnan, Dr. Aditya Ganesh, Dr. Aparna A, Dr. Neha Chaudhary, Dr Sudebi Roy
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Aim: The purpose of this study was to determine the prevalence of ocular surface disease symptoms and the state of the tear film among patients with glaucoma who are receiving topical intraocular pressure lowering therapy.
Methods: The Prospective observational cohort study was conducted in a Tertiary Hospital and Research Centre in Western Maharashtra from September 2020 to October 2022. 78 Patients (156 eyes) attending Ophthalmology OPD in a Tertiary Hospital and Research Centre in Western Maharashtra were included in the study.
Results: Majority of the patients in our study were males (67.9%), while 32.1% were females. Majority of the patients were in the 35-45 age group followed by >55 age group. The mean Intraocular pressure in the right and left eye was 27.4 mm Hg before the medication. The mean Schirmer 1 test scores in the right and left eye were 16.8 mm before the medication. The mean Schirmer 2 test scores in the right and left eye were 15.7 mm & 15.5 mm, respectively, before the medication. All patients had normal TBUT time in both right and left eye (>10 seconds). All patients had intact corneal sensation in right and left eye. Post-medication, the schirmer 1 was reduced in 66.7% of the patients, increased in 11.5% and remained same in 21.8% of the patients in right eye and left eye. Post-medication, the schirmer 2 was reduced in 66.7% of the patients, increased in 11.5% and remained same in 21.8% of the patients in right eye and left eye. TBUT was found abnormal among 7.7% of the patients in either eye, at 6 months after the anti-glaucoma medications.
Conclusion: Anti-glaucoma medication (E/D Timolol 0.5%) twice a day for a period of 6 months had significantly reduced TBUT, Schirmer-1 and Schirmer-2 among the glaucoma patients in our settings. Reduced corneal sensitivity has been noted in few patients. Anti-glaucoma medication had led to dry eye symptoms with severity ranging from moderate to severe in majority of the patients

Keywords

  • dry eye
  • glaucoma
  • ocular surface disease
  • Topical
  • XML
  • PDF 383.19 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 67
    • PDF Download: 94
European Journal of Molecular & Clinical Medicine
Volume 9, Issue 7
September 2022
Page 8601-8614
Files
  • XML
  • PDF 383.19 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 67
  • PDF Download: 94

APA

Dr Sudebi Roy, D. K. S. D. A. L. D. C. O. R. D. A. G. D. A. A. D. N. C. (2022). EVALUATION OF TEAR FILM STATUS IN PATIENTS USING ANTI-GLAUCOMA MEDICATION. European Journal of Molecular & Clinical Medicine, 9(7), 8601-8614.

MLA

Dr. Kilari Sindhu, Dr. Abhay Lune, Dr. Col OK Radhakrishnan, Dr. Aditya Ganesh, Dr. Aparna A, Dr. Neha Chaudhary, Dr Sudebi Roy. "EVALUATION OF TEAR FILM STATUS IN PATIENTS USING ANTI-GLAUCOMA MEDICATION". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 8601-8614.

HARVARD

Dr Sudebi Roy, D. K. S. D. A. L. D. C. O. R. D. A. G. D. A. A. D. N. C. (2022). 'EVALUATION OF TEAR FILM STATUS IN PATIENTS USING ANTI-GLAUCOMA MEDICATION', European Journal of Molecular & Clinical Medicine, 9(7), pp. 8601-8614.

VANCOUVER

Dr Sudebi Roy, D. K. S. D. A. L. D. C. O. R. D. A. G. D. A. A. D. N. C. EVALUATION OF TEAR FILM STATUS IN PATIENTS USING ANTI-GLAUCOMA MEDICATION. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 8601-8614.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus